We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

72 hedge funds and large institutions have $2.65M invested in Asensus Surgical, Inc. in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,247% more call options, than puts

Call options by funds: $3.11M | Put options by funds: $93K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less funds holding

Funds holding: 8272 (-10)

18% less capital invested

Capital invested by funds: $3.22M → $2.65M (-$575K)

39% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 23

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

Holders
72
Holders Change
-10
Holders Change %
-12.2%
% of All Funds
1.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
9
Reduced
16
Closed
23
Calls
$3.11M
Puts
$93K
Net Calls
+$3.02M
Net Calls Change
+$2.93M
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
1
Masters Capital Management
Georgia
$487K -$64K -132,553 -13%
Vanguard Group
2
Vanguard Group
Pennsylvania
$351K -$29.5K -61,131 -9%
SHI
3
SV Health Investors
Massachusetts
$276K
Renaissance Technologies
4
Renaissance Technologies
New York
$172K +$154K +318,467 New
Deutsche Bank
5
Deutsche Bank
Germany
$159K +$139K +287,606 +4,880%
BlackRock
6
BlackRock
New York
$152K -$438K -906,835 -76%
Mirae Asset Global Investments
7
Mirae Asset Global Investments
South Korea
$152K +$8.55K +17,718 +7%
BCM
8
Bridgeway Capital Management
Texas
$152K +$136K +280,895 New
Charles Schwab
9
Charles Schwab
California
$78K -$8.38K -17,370 -11%
PP
10
Paloma Partners
Connecticut
$76K +$68.2K +141,257 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$72K -$99.4K -205,974 -60%
Invesco
12
Invesco
Georgia
$62K -$7.09K -14,683 -11%
Morgan Stanley
13
Morgan Stanley
New York
$51K +$8.49K +17,599 +23%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$51K +$12.3K +25,400 +37%
Northern Trust
15
Northern Trust
Illinois
$33K -$79K -163,737 -73%
Bank of America
16
Bank of America
North Carolina
$33K +$22.6K +46,926 +316%
Jane Street
17
Jane Street
New York
$32K +$17.5K +36,290 +158%
Verition Fund Management
18
Verition Fund Management
Connecticut
$30K +$26.5K +55,000 New
AQR Capital Management
19
AQR Capital Management
Connecticut
$29K +$25.8K +53,510 New
Osaic Holdings
20
Osaic Holdings
Arizona
$22K +$4.95K +10,261 +34%
Goldman Sachs
21
Goldman Sachs
New York
$21K +$2.27K +4,693 +14%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$17K -$9.52K -19,729 -38%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$17K +$14.9K +30,876 New
CC
24
Centiva Capital
New York
$17K +$15K +30,997 New
TCM
25
Tradewinds Capital Management
Washington
$15K

ASXC Hedge Fund Activity: Q2 2020 in Review

72 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q2 2020, worth a combined $2.65M — down 18% from $3.22M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ASXC and 14 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $154K. The largest seller was Sabby Management, exiting entirely with an estimated $850K sold.

  • 72 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q2 2020, down from 82 in Q1 2020.
  • Funds reported $2.65M of Asensus Surgical, Inc. stock for Q2 2020, down 18% quarter-over-quarter.
  • 14 funds opened new Asensus Surgical, Inc. positions in Q2 2020 and 23 closed out, a net change of -9 holders.
  • The largest Asensus Surgical, Inc. buyer in Q2 2020 was Renaissance Technologies, an estimated $154K added.
  • The largest Asensus Surgical, Inc. seller in Q2 2020 was Sabby Management, an estimated $850K sold.

Based on aggregated 13F filings for Q2 2020.